Reduced Placental 11β-Hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: An analysis of possible mechanisms

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 10, 2001, Pages 4979-4983

  McTernan, C L ^a   Draper, N ^a   Nicholson, H ^a   Chalder, S M ^a   Driver, P ^a   Hewison, M ^a   Kilby, M D ^b   Stewart, P M ^a,c  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 11BETA HYDROXYSTEROID DEHYDROGENASE TYPE 2; CYTOKERATIN 8; MESSENGER RNA; UNCLASSIFIED DRUG; HYDROXYSTEROID DEHYDROGENASE;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ENZYME ACTIVITY; EVALUATION; FEMALE; FETUS GROWTH; GENETIC ANALYSIS; GENOME IMPRINTING; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; PLACENTA; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; TROPHOBLAST; ENZYMOLOGY; GENETICS; PHYSIOLOGY; PRENATAL DEVELOPMENT;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FETAL GROWTH RETARDATION; HUMANS; HYDROXYSTEROID DEHYDROGENASES; PLACENTA; PREGNANCY; RNA, MESSENGER;

EID: 0034740083     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.10.4979     Document Type: Article

References (44)

1. The fetal origins of hypertension
2. Glucocorticoid exposure in utero: New model for adult hypertension
3. Prenatal exposure to prednisone in humans and animals retards intrauterine growth
4. Placental restriction alters the functional development of the pituitary-adrenal axis in the sheep fetus during late gestation
5. Metabolic and endocrine findings in appropriate and small for gestation age fetuses
6. Abnormal adrenal steroidogenesis in growth retarded newborn infants
7. 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess
8. 11β-hydroxysteroid dehydrogenase
9. The human gene for 11 β-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization
10. Human kidney 11β-hydroxysteroid dehydrogenase is a high affinity NAD+-dependent enzyme and differs from the cloned "type I" isoform
11. Type 2 11β-hydroxysteroid dehydrogenase in human fetal tissues
12. Cloning and tissue distribution of the human 11β-hydroxysteroid dehydrogenase type 2 enzyme
13. Detection of human 11β-hydroxysteroid dehydrogenase isoforms using reverse transcriptase-polymerase chain reaction and localization of the type 2 isoform to renal collecting ducts
14. 11β-hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua
15. 11β-hydroxysteroid dehydrogenase activity of the human placenta during pregnancy
16. Human placental 11β-hydroxysteroid dehydrogenase: Evidence for and partial purification of a distinct NAD-dependent isoform
17. Type 2 11β-hydroxysteroid dehydrogenase in human placenta and fetal membranes: Its relationship to birth weight and putative role in fetal adrenal steroidogenesis
18. Variation in placental type 2 11β-hydroxysteroid dehydrogenase activity is not related to birth or placental weight
19. Differential expression of 11β-hydroxysteroid dehydrogenase types 1 and 2 in human placenta and fetal membranes
20. Expression of type 2 11 β-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life
21. Dysfunction of placental glucocorticoid barrier: Link between fetal environment and adult hypertension?
22. Apparent mineralocorticoid excess due to 11 β-hydroxysteroid dehydrogenase deficiency: A possible cause of intrauterine growth retardation
23. Current topic: Confined placental mosaicism and intrauterine fetal development
24. Ontogeny of placental 11β-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth retardation
25. Cloning and sequence of cDNA for human placental cytokeratin 8. Regulation of the mRNA in trophoblastic cells by cAMP
26. Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11β-hydroxysteroid dehydrogenase type 2 gene
27. A new polymorphic restriction site in the human 11 β-hydroxysteroid dehydrogenase type 2 gene
28. Regulation of 11β-hydroxysteroid dehydrogenase activity in the baboon placenta by estrogen
29. Human 11β-hydroxysteroid dehydrogenase: Studies on the stably transfected isoforms and localization of the type 2 isozyme within renal tissue
30. Purification of 11 β-hydroxysteroid dehydrogenase type 2 from human placenta utilizing a novel affinity labelling technique
31. Regulation of 11β-hydroxysteroid dehydrogenase type 2 activity and mRNA in human choriocarcinoma cells
32. Differential regulation of 11β-hydroxysteroid dehydrogenase types 1 and 2 by nitric oxide cultured human placental trophoblast and chorionic cell preparation
33. Analysis of the promoter of the NAD+ dependent 11 β-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells
34. Placental 11β-hydroxysteroid dehydrogenase: A key regulator of fetal glucocorticoid exposure
35. Activation of the baboon foetal pituitary-adrenocortical axis at midgestation by estrogen: Enhancement of foetal pituitary proopiomelanocortin mRNA expression
36. Inhibition of 11 β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring
37. Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2
38. Inhibition of maternal and fetal 11β-hydroxysteroid dehydrogenase type 2 (11βHSD2) across gestation does not alter birth or placental weight in the mouse
39. Ontogeny and sexual dimorphic expression of mouse type 2 11ββ-hydroxysteroid dehydrogenase
40. The ontogeny of 11 β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development
41. Expression of 11β-hydroxysteroid dehydrogenase isozyme and corticosteroid hormone receptors in primary cultures of human trophoblast and placental bed biopsies
42. CpG islands in vertebrate genomes